Drug Trial Radar · NCT00449150
Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
Last checked: Nov 19, 2026Latest source record: Aug 3, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
667
Actual
Start
Mar 2007
Primary completion
Jun 2009
Study completion Dec 2009
Sponsor
- Lead sponsor
- AEterna ZentarisIndustry
- Sponsor type
- Industry
- First posted
- Mar 19, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Male only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Benign Prostatic Hypertrophy (BPH) is a common and bothersome condition of aging men. It is characterized by an enlargement of the prostate occurring in human male over the age of 50 which increases in prevalence with age, and among those aged 50 to 80, about 40% report moderate or severe urinary symptoms of prostatism. The aim of treatment is to improve patients' quality of life which primarily depends on the severity of the symptoms of BPH. Current treatments of BPH have a benefit / risk ratio which leaves room for improvement. For this study, study medication (Cetrorelix pamoate or placebo) is administered by injection in the buttocks (Intramuscular). All patients completing the double-blind portion (Week 0 to 52) are eligible to receive the active drug during the open-label part of the study (Week 52 to 90).
Conditions
- Benign Prostatic Hypertrophy
Interventions
Cetrorelix 78 mg + 78 mgDrug
Cetrorelix 78 mg + 52 mgDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- International Prostate Symptoms Score (IPSS)Time frame: Baseline and 52 weeks
Locations
68 sites in 4 countries. Site status is shown where the registry gives one.
Medical Affiliated Research Center, Inc.
Huntsville, Alabama
Urology Group of Westrn Arkansas
Fort Smith, Arkansas
South Orange County Medical Research Center
Laguna Hills, California
California Professionnal Research
Newport Beach, California
William G. Moseley
San Diego, California
West Coast Clinical Research
Tarzana, California
Western Clinical Research, Inc.
Torrance, California
Urology Research Options
Aurora, Colorado
Urologic Oncology
Aurora, Colorado
Genitourinary Surgical Consultants
Denver, Colorado
Connecticut Clincal Research Center
Middlebury, Connecticut
South Florida Medical Research
Aventura, Florida
Tampa Bay Medical Research
Clearwater, Florida
Atlantic Urological Associates
Daytona Beach, Florida
Miami VACM
Miami, Florida
Florida Healthcare Research
Ocala, Florida
Florida Urologist Specialists
Sarasota, Florida
Southeastern Research Group
Tallahassee, Florida
Southwestern Medical Research Institute
Columbus, Georgia
Northwestern University Feinberg School of Medecine
Chicago, Illinois
Welborn Clinic
Evansville, Indiana
Northeast Indiana Research, LLC
Fort Wayne, Indiana
Kansas City Urology Care
Overland Park, Kansas
Four Rivers Clinical Research
Paducah, Kentucky
Myron I. Murdock M.D. LLC
Greenbelt, Maryland
Michigan Institute of Urology
Saint Clair Shores, Michigan
Washington University
St Louis, Missouri
Metropolitan Urological Specialists
St Louis, Missouri
Quality Clinical Research
Omaha, Nebraska
Delaware Valley Urology, LLC
Woodlane, New Jersey
Urology Group Of New Mexico
Albuquerque, New Mexico
Medical & Clinical Research Associates
Bay Shore, New York
Urological Surgeons of Long Island, Clinical Research Division
Garden City, New York
New York University School of Medecine
New York, New York
University Urology
New York, New York
Hudson Valley Urology
Poughkeepsie, New York
Northeast Urology Research
Concord, North Carolina
Parkhurst Research Oganization Inc.
Bethany, Oklahoma
Carolina Urologic Research Center
Myrtle Beach, South Carolina
Vanderbilt University medical Center
Nashville, Tennessee
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.